Jamie Bridge

IDPC Secretariat

Jamie Bridge

Executive Director

Jamie is IDPC’s Executive Director, leading on the coordination and development of the network, its strategy and work. Jamie leads on international advocacy efforts on drug policy and human rights, representing IDPC at a range of international events and in the media, as well as the financial and administrative management of the organisation.

Jamie joined IDPC in 2012, initially as the Senior Policy and Operations Manager, and then later moving into the roles of Chief Operating Officer and then Deputy Director – before being appointed as Executive Director in 2026.

From 2018 to 2023, Jamie was also the Chair of the Vienna NGO Committee on Drugs (VNGOC), and he has also been Chair of the National Needle Exchange Forum in England. Prior to joining IDPC, Jamie worked in Geneva as a harm reduction technical expert at the Global Fund to Fight AIDS, Tuberculosis and Malaria, and at Harm Reduction International in London, for whom he has also served as a Trustee. Jamie started his career working in a harm reduction service in the UK, and he has an MSc in drug policy and a BSc in psychology.

Translations

Related Content

13 August 2026
IDPC labelled 'undesirable' by the Russian Federation

IDPC labelled 'undesirable' by the Russian Federation

IDPC’s designation as an ‘undesirable organisation’ exemplifies Russia’s crackdown on civil society and human rights and, while it will not deter our work, it poses serious risks for people in Russia who engage with or share it.
CND 69: Key issues and opportunities

CND 69: Key issues and opportunities

Online
25 February 2026
The webinar will discuss the key issues that are likely to structure the debates, including in relation to tabled resolutions, and present how IDPC member organisations have used this forum for their advocacy.
28 August 2024
Introducing IDPC’s new Strategic Plan for 2024-2027!

Introducing IDPC’s new Strategic Plan for 2024-2027!

IDPC’s new Strategic Plan for 2024-2027 outlines an ambitious approach to advance drug policy reform, addressing pivotal challenges for our movement in relation to funding, equitable regulation, and media impact, to name a few.
5 April 2024
CND 67: A meeting full of milestones

CND 67: A meeting full of milestones

This year's CND marked a departure from conservative groupthink, fostering genuine debate —including as led by Colombia and the US, tensions among UN agencies' stances, and increased civil society participation.